• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Reocclusion (1985); Patient Problem/Medical Problem (2688)
Event Date 10/01/2018
Event Type  Injury  
Manufacturer Narrative
Journal article title: "variants of endovascular revascularization of lower limbs with critical ischemia doe extensive atherosclerosis and assessment of their effectiveness." georgian medical news no 10 (283) 2018.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A retrospective analysis of the results of endovascular operations on the arteries of the lower extremities was performed in 209 patients.An ultrasound examination of arterial vessels was carried out for the examination of the arterial system.Based on clinical and angiographic data, several variants of endovascular revascularization of the lower extremities were used.In 17 patients there was a recoil phenomenon, which required to prevent the early restenosis of stenting of the parotid artery area.In 11 cases (5.3%) subintimal angioplasty was performed based on certain indications.In 17 (8.1%) patients, balloon angioplasty was used using in cylinders.Pact admiral (medtronic inc.Usa) with free pac coating containing urea and paclitaxel.In all cases, this method of angioplasty was used for vasoballoone division of the thigh popliteal area.The evaluation of the results of endovascular surgical interventions was carried out at the discharge of the patient from the hospital, after 3 and 6 months after the operation.It was based on complaints of the patient, on the data of objective examination and ultrasound dopplerography of the arteries with the measurement of the ankle and shoulder index (kpi).Also, in order to assess the state of the microcirculatory bed, a study of partial pressure of oxygen in the surface soft tissues of the lower limb (transcutaneous oximetry) was performed.After analyzing the results of restorative operations, clinical success in the first 6 months was achieved in 171 (81.8%) patients.Among them, a significant improvement in the limb was reported in 94 (45.0%) patients, moderate improvement was noted in 73 (34.9%) patients, unchanged in 26 (12.4%) cases, and a moderate deterioration at 16 (7.7%) patients.At 14th day after the restoration of blood supply, a natural increase in the values of tcpo2 in the vast majority of patients (179 - 85.0%).In the further dynamic observation, the maximum increase in tcpo2 have occurred on 1-2 month.The fluctuations of the tcpo2 levels after endovascular surgery are explained by the presence of postoperative edema of the foot and shin that disappear over time, as well as the probable adaptation of the microcirculation to the restored blood flow.Reperfusion tissue injury and, as a result, local inflammation may be an additional factor in the delayed growth of oxygen tension.Cumulative vascular passage after endovascular operations was: 1st month - 94.5%, 2nd month - 92.3%, 6 month - 87.4%, one year later - 78.1%, in 2 years - 69.8%.The highest frequency of restenosis and reocclusion was noted in the first 6 months.All patients had a successful repeated endovascular reconstruction of the lesion area.Cumulative limb preservation after endovascular surgery was: 1 month- 100%, 2 months - 94.3%, 6 months - 90.6%, in 2 years - 84.1%.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8631598
MDR Text Key145762234
Report Number9612164-2019-01889
Device Sequence Number1
Product Code ONU
Combination Product (y/n)N
Reporter Country CodeUP
PMA/PMN Number
P140010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 05/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/15/2019
Initial Date FDA Received05/22/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-